medline.ch Onkologie Respirationstrakt

	A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients. Transl Lung Cancer Res Girard N, Tan D, Cortinovis D, Lopes G, Voon PJ, Taylor MA, Ghali N, Zhan L, Xu S, Naicker K, Peters S. PMID: 41510396 [PubMed - in process]
	Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study. Transl Lung Cancer Res Huang K, Hu Z, Pan S, Qian J, Wu X, Wang H, Wang K, Lu H, Dong H, Chu T, Wang J. PMID: 41510395 [PubMed - in process]
	Clinical characteristics of post-operative N2 nodal upstaging in non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Choi SY, Song MJ, Kwon BS, Kim YW, Park JS, Cho S, Lee JH, Lee CT, Lim SY. PMID: 41510389 [PubMed - in process]
	A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II-IIIB non-small cell lung cancer patients with EGFR mutation. Transl Lung Cancer Res Chen Y, Mei J, Gao G, Zhang B, Li Y, Peng Z, Li C, Gan F, Pu Q, Liu C, Yang W, Liu L, Wang Y. PMID: 41510386 [PubMed]
	Exploring perioperative treatment for non-small cell lung cancer patients harboring EGFR mutation: a real-world multicenter cohort study. Transl Lung Cancer Res Zhou Y, Wei Z, Li M, Li J, Meng R, Wu F, Jiang G, Zhang B, Chen B, Zhou C, Jiang W, Zeng L, Wu L, Yan X, Pu X. PMID: 41510384 [PubMed - in process]
	Development of a multimodal fully automated ensemble model to predict EGFR mutation and efficacy of EGFR-TKI in non-small cell lung cancer. Transl Lung Cancer Res Xu S, Miyawaki T, Shukuya T, Suzuki K, Shimamura SS, Matsuda H, Kanemaru R, Asao T, Mimori T, Otsuka Y, Takahashi K. PMID: 41510381 [PubMed - in process]
	Targeting ferroptosis to overcome drug resistance in lung cancer. Transl Lung Cancer Res Sheng P, Jin J, Liu H, Sun C, Chen Y, Chen X, Ma D, Shen J. PMID: 41510378 [PubMed - in process]
	The effects of neoadjuvant sintilimab versus pembrolizumab combined with chemotherapy on resectable non-small cell lung cancer: a multicenter propensity score-matched study. Transl Lung Cancer Res Sun Y, Gao Z, Luo Z, Tong L, Zhang Y, Dong X, Wang J, Li W, Li Z, Qiao W, Chen X, Duan H, Yan X. PMID: 41510377 [PubMed - in process]
	Computer-aided quantitative stromal analysis: a comprehensive investigation of its prognostic significance in lung squamous cell carcinoma. Transl Lung Cancer Res Zhang X, Chen J, Bu X, Huang Q, Li Y, Zhang D, Yang J, Feng A, Meng F, Li W, Sun Q, Xu C. PMID: 41510375 [PubMed - in process]
	Development and validation of machine learning models based on blood routine tests and tumor markers in early screening of primary bronchogenic lung cancer. Transl Lung Cancer Res Deng W, Pan L, Wang H, Liu Y, Peng X, Yang C, Li J, Han B. PMID: 41510374 [PubMed - in process]
	Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape. Transl Cancer Res Herrmann A, Grant C, Bazhenova L. PMID: 41510126 [PubMed - in process]
	An updated review on systemic therapy for brain metastases in non-small cell lung cancer. Transl Cancer Res Louis S, Aboubechara JP, Saigal K, Cao T, Nagpal S. PMID: 41510114 [PubMed - in process]
	Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer. Transl Cancer Res Xia J, He T, Hu Y, Zhou D, Zou D, Li Y, Zhang M, Li B, Wang M, Liu X, Huang Z, Su S, Peng J. PMID: 41510072 [PubMed - in process]
	Human papillomavirus infection and its association with lung cancer: a case-control study (2011-2019). Iran J Microbiol Shakeri Z, Makvandi M, Mirzaei H, Kanani M, Jalilian S. PMID: 41510037 [PubMed - in process]
	Patient characteristics associated with death literacy in advanced non-small-cell lung cancer: A preliminary single-centre cross-sectional study. Palliat Care Soc Pract Lin GF, Yeh YL, Shun SC, Yang CY, Lin CP. PMID: 41509987 [PubMed]
	Advances in targeting KRAS mutations: A promising approach for the treatment of nonâ€‘small cell lung cancer (Review). Oncol Rep Sharma U, Song J, Kandu H, Zhu Y, Dai Z. PMID: 41508946 [PubMed - indexed for MEDLINE]
	The current state of polygenic scores for the development of lung cancer: a systematic review and validation in UK Biobank. Br J Cancer Galal B, Dennis J, Antoniou AC, Harrison H. PMID: 41507563 [PubMed - as supplied by publisher]
	Pulmonary fibrosis and its rehabilitation after radiation therapy for breast cancer. Br J Radiol Nazarbek S, Kaidarova D, Ishkinin Y, Ossikbayeva S, Goncharova T. PMID: 41507076 [PubMed - as supplied by publisher]
	Racial/Ethnic Disparities in Non-Small Cell Lung Cancer Mortality in the U.S., 2000-2020: A Population-Based Study. QJM Yin Y, Gao Y, Yi H, Wang Y, Zhang G, Mao Y, Wang J. PMID: 41506894 [PubMed - as supplied by publisher]
	Intelligent Breathing Training Using a Digital Device for Postoperative Lung Cancer Patients: A Randomized Controlled Trial. Biol Res Nurs Chen L, Liu J, Xia H, Jiang L, Shen S. PMID: 41506643 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 155477

Seite 1 von 7774

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung